Budget Impact Analysis of Implementing Tenders Between The Branded Infliximab And Its Biosimilars In The Public Hospitals of Paris
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2275
https://www.valueinhealthjournal.com/article/S1098-3015(15)04351-X/fulltext
Title :
Budget Impact Analysis of Implementing Tenders Between The Branded Infliximab And Its Biosimilars In The Public Hospitals of Paris
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04351-X&doi=10.1016/j.jval.2015.09.2275
First page :
A639
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1691